Private practice with Dr Seth BilazarianView all posts »
Simvastatin: Now what?Jul 5, 2011 08:50 EDT
Finding the right path for patients on simvastatin in light of the recent FDA recommendation is a dilemma as we wade through the recommendation itself, manufacturer information, pharmacy letters, and media coverage. How do we manage the simvastatin/calcium-channel-blocker interaction? What is the best method to review patients' records? How will (soon to be) generic atorvastatin fit into the equation? What is your approach?